
About Claris Lifescences
Claris Lifescences is a publicly listed company based in Ahmedabad (India) founded in 1994. Manufacturing of sterile injectable medications is facilitated online. Claris Lifescences has raised $20 million across 4 funding rounds from investors including The Carlyle Group, Orbimed and Signet Healthcare Partners. The company has 162 employees. Its chief executive, as recorded, is Arjun Handa. Its Indian entity Claris Lifesciences Limited reported revenue of βΉ4.1 Lakh. Its focus areas include Traditional Pharmaceuticals, Generics and Injectables.
Company details
Claris Lifescences was founded in 1994 in Ahmedabad, India, within the pharmaceutical sector. Sterile injectable medications are produced for multiple therapeutic areas, with operations centered on an online platform. Formats such as vials, ampoules, and infusion bags are supplied to support clinical environments. Leadership is provided by CEO Arjun Handa, ensuring focus on manufacturing and delivery processes.
- Headquarters Ahmedabad, India
- Employees 162
- Stage Public
- SectorsHealthcare
- Website clarislifesciences.com
- Social LinkedIn
- Legal Name Claris Lifesciences Limited
- Date of Incorporation 19 Jul, 1994
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹4.1 Lakh
FY 2021 · -91% YoY
- Net Loss-₹27.3 Lakh
FY 2021 · -661% margin
- EBITDA-₹27.3 Lakh
FY 2021 · -660% margin
- Total Equity Funding$20M (USD)
in 4 rounds
- Latest Funding Round$37M (USD), Post-IPO
Jan 2014
- InvestorsThe Carlyle Group
& 2 more
- Employee Count162
Associated legal entities of Claris Lifescences
Claris Lifescences operates through Claris Lifesciences Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Claris Lifesciences Limited CIN U85110GJ1994PLC022543 | Amalgamated | 19 Jul 1994 | Ahmedabad, Gujarat | ₹0.0 Cr | 162 | 10 | View details |
Funding Insights of Claris Lifescences
Claris Lifescences has successfully raised a total of $20M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $37 million completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20M
- Total Rounds 4
- Last Round Post-IPO β $37M
- First Round $20M
(Mar 2006)
- Investors Count 3
All 4 funding rounds of Claris Lifescences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2014 | $37M | Post-IPO | β | β | |
| Apr 2013 | $3.92M | Post-IPO | β | β | |
| Jul 2012 | $4.13M | Post-IPO | β | β | |
| Mar 2006 | $20M | Private Equity Round | β | β |
3 investors in total: 3 institutional.
Investors in Claris Lifescences
Claris Lifescences has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include The Carlyle Group, Orbimed and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward multiple sectors. | 1986 | carlyle.com | ||
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
PE firm investing in North America and Europe | signethealthcarepartners.com | New York, United States |
Investor details for Claris Lifescences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Claris Lifesciences Limited (Claris Lifescences)
Claris Lifesciences Limited is the primary company behind Claris Lifescences. The board of Claris Lifesciences Limited currently have 7 directors; the longest-serving is Aditya Sushilkumar Handa, appointed in 2006. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aditya Sushilkumar Handa DIN 00308513 | Director | 13 Jun 2006 | 20 yrs 5 mo | Claris Lifesciences Limited |
| Surrinder Lal Kapur DIN 00033312 | Director | 26 Sep 2008 | 18 yrs 1 mo | Claris Lifesciences Limited |
| Anup Pravin Shah DIN 00293207 | Director | 23 Feb 2013 | 13 yrs 8 mo | Claris Lifesciences Limited |
| Kiritkumar Himatlal Kanjaria DIN 00650069 | Company Secretary | 13 Apr 2013 | 13 yrs 7 mo | Claris Lifesciences Limited |
| Chandrasingh Shivrambhai Purohit DIN 00199651 | CFO | 09 May 2014 | 12 yrs 6 mo | Claris Lifesciences Limited |
| Arjun Sushilkumar Handa DIN 00159413 | Managing Director | 26 Sep 2014 | 12 yrs 1 mo | Claris Lifesciences Limited |
| Shyamsunder Kashiram Sharma DIN 07563680 | Director | 20 May 2017 | 9 yrs 5 mo | Claris Lifesciences Limited |
People of Claris Lifescences
1 people are tracked at Claris Lifescences (1 in leadership); the tracked headcount is 162.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for Claris Lifescences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Claris Lifescences
Figures of Claris Lifesciences Limited, the primary company behind Claris Lifescences, for FY 2021. Revenue was ₹4.1 Lakh (-91% year on year). Net loss was -₹27.3 Lakh (-661% margin). EBITDA was -₹27.3 Lakh (-660% margin). Revenue has grown at a compounded annual rate of -86% over three years and -81% over five years.
- ₹4.1 LakhRevenue · FY 2021 · -91% YoY
- -₹27.3 LakhNet loss · -661% margin
- -₹27.3 LakhEBITDA · -660% margin
- ₹54.57 CrPaid-up capital
- 162Employees (provident fund records)
- -86%Revenue CAGR, 3 years
- -81%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Claris Lifesciences Limited are on its company page.
Detailed financial statements for Claris Lifescences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Claris Lifescences
4 dated milestones of Claris Lifescences across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Claris Lifescences is founded.
- Funding First funding round of $20.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $37.0M.
Web traffic of Claris Lifescences
Websites that share an audience with Claris Lifescences (clarislifesciences.com).
Websites whose visitors overlap most with Claris Lifescences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dishmangroup.com | 100% | View details | |||
pharma.com | pharma.com | 84% | β | ||
| yashpharma.com | 84% | View details | |||
rspharmchem.com | rspharmchem.com | 84% | β | ||
petrone.it | petrone.it | 84% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 19 similar websites and full traffic analytics for Claris Lifescences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Claris Lifescences (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 72.52 M | 1,115 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 4,050 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.44 B | 19,801 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Claris Lifescences
Complete news archive for Claris Lifescences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Claris Lifescences
Claris Lifescences was founded in 1994 and raised its 1st funding round 12 years after it was founded.
Claris Lifescences is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Arjun Handa is the CEO of Claris Lifescences, as recorded in our data.
Claris Lifescences is a funded company, having raised a total of $20M across 4 funding rounds to date. The company's 1st funding round was a Private Equity Round of $20M, raised on Mar 2006.
Claris Lifescences has 162 employees.
The primary company behind Claris Lifescences, Claris Lifesciences Limited, reported revenue of βΉ4.1 Lakh for FY 2021, down 91% year on year.
Claris Lifescences was founded in 1994 in Ahmedabad, India, within the pharmaceutical sector. Sterile injectable medications are produced for multiple therapeutic areas, with operations centered on an online platform. Formats such as vials, ampoules, and infusion bags are supplied to support clinical environments. Leadership is provided by CEO Arjun Handa, ensuring focus on manufacturing and delivery processes.
Claris Lifescences has 3 investors. Key investors include The Carlyle Group, Orbimed, and Signet Healthcare Partners.
Claris Lifescences operates through Claris Lifesciences Limited.
The legal entities of Claris Lifescences currently have 9 directors, including Chandrasingh Shivrambhai Purohit, Arjun Sushilkumar Handa, Aditya Sushilkumar Handa and others.
